RB
Reprise Biomedical, Inc.
SEC filingBiotechnology · Plymouth, MN
Amount raised$9.2Msold at filing
Total offering$10M$754K still open
Investors in the raise43count reported to the SEC
FiledJul 1, 2026first sale May 14, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jake IsenburgExecutive Officer
Phil NalboneDirector
Heather KotilaExecutive Officer
Jerrod KruegerExecutive Officer
Tom KouchoukosExecutive Officer
Howard RootDirector
Carrie PowersExecutive Officer, Director
Greg SmockExecutive Officer
Steve JagodzinskiExecutive Officer
Alan WoldtDirector
Ronald EibensteinerDirector
Jeff DuncanExecutive Officer
Executive officers, directors and promoters as listed on the Form D.